Cosentyx is a biologic drug used for the treatment of plaque psoriasis and psoriatic arthritis. It works by blocking a specific part of the immune system called interleukin-17A (IL-17A). Cosentyx is administered through subcutaneous injection. The emergence of humanized monoclonal antibodies that selectively target specific cytokines like IL-17A has transformed the treatment of autoim... https://timessquarereporter.com/health/cosentyx-drug-market-is-anticipated-to-witness-high-growth-owing-to-rising-prevalence-of-psoriasis-and-psoriatic-arthritis